Disclosures
LGA, CM, LCH, CTS
AAK: Research investigator for Alexion, Amgen, Ascendis, Chugai, Radius, Takeda, and Ultragenyx. MRR: Research investigator for Ascendis Pharma Inc. PS: Research investigator for Ascendis Pharma A/S. TJV: Advisory board member for Takeda; receives consulting fees from Ascendis Pharma Inc.; and research investigator for Ascendis Pharma Inc. DMS: Advisory board member for Amolyt; receives consulting fees from Takeda; and research investigator for Ascendis Pharma Inc. CG: Advisory board member for Novo Nordisk; grant recipient from Novo Nordisk; and research investigator for Shire and Ascendis Pharma Inc. AP: Research investigator for Ascendis Pharma A/S. CM: Research investigator for Ascendis Pharma A/S. BLC: Advisory board member for Takeda, Shire, PARADIGHM Registry Steering Committee, Ascendis Pharma Inc; grant recipient from Takeda, Shire, Chugai, and Ascendis Pharma Inc.; and research investigator for Ascendis Pharma Inc. LGA: Research investigator for Ascendis Pharma Inc and Takeda; and speaker for Abbvie and Clarus. LCH: Advisory board member for Amgen, Kiowa Kirin International, and UCB. LK: Advisory board member for Alexion; research investigator for Ascendis Pharma Inc; and speaker for Radius, Amgen, and Alexion. SP, XA, WE, ARS, JU, CTS, and ADS: Employee of Ascendis Pharma Inc. LR: Advisory board member for Takeda and Amolyt; grant recipient from Kyowa Kirin and Takeda; and research investigator for Ascendis Pharma A/S, Takeda, and Kyowa Kirin.